🧠 Treating #IDHmutant #glioma can be tricky - watch-and-wait, #vorasidenib, or radiochemo? 🤔 📚 Our new paper in #NeuroOncology shows amino acid #PET adds prognostic value in a large bi-centric cohort (n=457) at @lmu-klinikum.bsky.social & @meduniwien.ac.at. [1/2] doi.org/p382

🚀 #ATTRACT is growing! ⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT. 🎉 Milestone: 1st patient enrolled in Wiener Neustadt! #NeuroOncology #PrecisionMedicine #CancerResearch

🧠 Just published in @thelancetoncol.bsky.social: Updated RANO and EANO recommendations on the clinical use of PET imaging in gliomas. 🔗 Read more: www.thelancet.com/journals/lan... #NeuroOncology #Glioma #PETimaging #EANO #RANO #BrainTumor #LancetOncology

🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy. Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀 youtu.be/NfxxMZ_xmF4

🚀🧠 Exciting science ahead 🔬- follow us for further updates and insights! #glioma #glioblastoma #clinicaltrial #research #btsm #neurooncology #precisionmedicine #oncology

🧠 New EORTC survey shows PET imaging is widely available and used across European brain tumour centres. With data from 103 centres in 20 countries, the findings support PET-based endpoints in future trials. 🔗 Find out more: www.eortc.org/blog/2025/07... #EORTCbrain #PETImaging

Live from @nmnsymposium.bsky.social in Vienna: introduction of first RANO criteria for response assessment of brain metastases based on amino acid PET - with simultaneous publication in Nature Medicine. Learn more: www.nature.com/articles/s41... #braincancer #PETimaging

Are you making an impact in #NeuroOncology research? The #EANOResearchAward honors outstanding contributions in the field. Apply now for a chance to be recognized at #EANO2025 in Prague! 📝 Nomination deadline: May 15 📩 Send your application to: [email protected] Learn more: www.eano.eu #EANO #btsm

📢 Early Bird Registration open until tomorrow for #NMN2025- register today: www.nmn-society.org/registration/!

1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786

🤩WOW! A total of 60 abstracts from 18 countries from all around the globe were submitted for #NMN2025! Cutting edge research on gliomas, meningiomas, brain metastases that will advance #PET imaging and #theranostics! Register today and join us: nmn-society.org/registration/!

Original publication: Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments academic.oup.com/neuro-oncolo....

Temozolomide chemotherapy for patients with newly diagnosed #glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?https://academic.oup.com/nop/article/doi/10.1093/nop/npaf006/7959516 @neuroonc.bsky.social @eanoassociation.bsky.social @eortc.bsky.social

💫 After last years highly successful meeting preparations for #NMN2025 are in full swing. Join us on May 09/10 in Vienna and submit your abstracts📝by February 02nd: nmn-society.org/abstracts/

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0. link.springer.com/article/10.1... #btsm @eanoassociation.bsky.social

That’s a wrap on #SNO2024 in Houston! ✨ The #EANO team had an amazing time sharing knowledge, meeting outstanding colleagues and friends, and being part of such an inspiring event. Thank you, @neuroonc.bsky.social, for hosting this great conference! #neurooncology #braintumor #cancer #btsm

Excited to make my first post on @bsky.app during a great #SNO2024 in Houston - with a true legend in #neurooncology being awarded the Victor Levin Award for his lifetime achievements. Congrats @martinvandenbent.bsky.social! 🎉🧠🚀 #glioma #btsm @neuroonc.bsky.social @eanoassociation.bsky.social